CervoMed Inc. 8-K

What Happened

• CervoMed Inc. announced on June 22, 2026 that it closed a previously announced registered direct offering priced at‑the‑market under Nasdaq rules. The company sold 2,500,000 shares of common stock at $4.00 per share, for a total purchase price of $10,000,000. The company furnished a press release (Exhibit 99.1) reporting the closing.

Key Details

• Offering closed: June 22, 2026 (reported in Form 8‑K).
• Shares sold: 2,500,000 common shares.
• Price per share: $4.00.
• Gross proceeds: $10,000,000 (2,500,000 × $4.00). Press release included as Exhibit 99.1.

Why It Matters

• The offering increases CervoMed’s cash resources by $10.0M (before any fees or expenses), which can affect the company’s liquidity and ability to fund operations or development programs.
• Issuing 2.5M new shares dilutes existing shareholders’ ownership; investors should monitor future filings or company statements for the planned use of proceeds and any impact on share count or capital structure.
• This 8‑K is a Regulation FD/Other Events disclosure notifying the market of the transaction; additional details may appear in subsequent SEC filings or company announcements.